-
DOES LONG-TERM EXPOSURE TO OPIOID LEAD TO HIGHER RISK OF BREAST CANCER RECURRENCE? AN OBSERVATIONAL STUDY USING U.S. POPULATION DATA
Mar 18, 2026, 21:38 PM -
IDENTIFYING MIGRAINE IN PRIMARY CARE WORKFLOWS: PREVALENCE, RISK SIGNALS, AND PREDICTIVE TOOLS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (RHC1-INH) VS SEBETRALSTAT FOR THE TREATMENT OF SEVERE OR VERY SEVERE HEREDITARY ANGIOEDEMA (HAE) ATTACKS
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH AML TREATED WITH POST-TRANSPLANT MAINTENANCE THERAPY
Mar 18, 2026, 21:38 PM -
CARE-PROCESS DETERMINANTS OF HEALTHCARE TRANSITION SERVICES AMONG US ADOLESCENTS WITH SPECIAL HEALTH CARE NEEDS: ANALYSIS OF THE 2022-2023 NATIONAL SURVEY OF CHILDREN’S HEALTH
Mar 18, 2026, 21:38 PM -
CAN LINKED CLAIMS-EHR DATA BE USED TO GENERATE SYNTHETIC DATA? AN EVALUATION OF THE MARKETSCAN-VERADIGM LINKED CLAIMS + EHR DATABASE
Mar 18, 2026, 21:38 PM -
A LIKELIHOOD-AUGMENTED VIRTUAL INCONSISTENCY-ADJUSTED ANALYSIS FRAMEWORK FOR ASSESSING ROBUSTNESS IN A STAR-SHAPED NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT OF FARICIMAB-TREATED DIABETIC MACULAR EDEMA: A LINKED ANALYSIS OF ADMINISTRATIVE CLAIMS AND IRIS REGISTRY DATA
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE HEMOSTASIS-RELATED COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING MYOMECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
POPULATION PHARMACOKINETIC MODELING OF A NOVEL ONCE-DAILY LITHIUM CARBONATE EXTENDED RELEASE (XR) BI-LAYER MATRIX FORMULATION TO SUPPORT FORMULATION SWITCHING AND PEDIATRIC DOSING
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE LIFETIME HEALTH AND SOCIETAL BENEFITS OF TIMELY DIAGNOSIS AND ACCESS TO APPROVED TREATMENTS IN ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE (ACHR-AB+) GENERALIZED MYASTHENIA GRAVIS (GMG) IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
YEARS LOST: QUANTIFYING THE HUMAN COST OF DELAYED GENETIC DIAGNOSIS
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC DISPARITIES IN TREATMENT ACCESS FOR TEXAS MEDICAID PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Mar 18, 2026, 21:38 PM -
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND RISK OF PARKINSON’S DISEASE IN PATIENTS WITH OBESITY
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH PRESCRIBED OPIOID USE IN U.S. ADULTS WITH LONG COVID
Mar 18, 2026, 21:38 PM -
BREAK EVEN ANALYSIS FOR CONTRACEPTION PRESCRIBING SERVICES IN COMMUNITY PHARMACIES
Mar 18, 2026, 21:38 PM -
WHAT MATTERS MOST TO PATIENTS IN WARFARIN MODELS OF CARE: A QUALITATIVE STUDY
Mar 18, 2026, 21:38 PM -
A DESCRIPTIVE COMPARISON OF U.S. MEDICARE IRA NEGOTIATED PRICES AND AVERAGE MFN BENCHMARKS FOR PART D DRUGS
Mar 18, 2026, 21:38 PM -
HOSPITALIZATION BURDEN IN PULMONARY ARTERIAL HYPERTENSION: EVIDENCE FROM SYSTEMATIC REVIEWS OF RCTS AND RWS
Mar 18, 2026, 21:38 PM -
GENERATIVE AI SECURES SYNTHETIC DATASETS OF NSCLC TRIAL COHORTS FOR RWD ANALYSIS: A PRIVACY-PRESERVING CASE STUDY
Mar 18, 2026, 21:38 PM
